Funding Received
$16 Million in 3 Rounds from 4 Investors
Most Recent Funding
$2.1 Million Series B on May 9, 2011
Headquarters:
Berlin
Description:
caprotec bioanalytics developed a proprietary capture protein technology to reduce the complexity of protein mixtures and samples.
Categories:
Biotechnology
Website:
http://www.caprotec.com

Detailed Description

Update

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.

caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Current Team (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Berlin,

    DEU

Images (1)

Update
  • 88d36a8a2d2e5d83d2aba605f9d5ba36